Analysts Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $73.83

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among brokerages […]

Related Keywords

Stifel Nicolaus ,Georgew Lemaitre ,Davidb Roberts ,Nasdaq ,Conestoga Capital Advisors ,Lemaitre Vascular ,Congress Asset Management Co ,Lemaitre Vascular Inc ,Copeland Capital Management ,Barrington Research ,Vanguard Group Inc ,Keycorp ,Lemaitre Vascular Company Profile ,Securities Exchange Commission ,Get Free Report ,Maitre Vascular ,Director David ,Exchange Commission ,Capital Advisors ,Capital Management ,Congress Asset Management ,Asset Management ,Get Free ,Lemaitre Vascular Daily ,